ARCHIVES

User Fees Proposed For FDA Oversight Services; Industry Groups Call It “Tax On Innovations”

This article is from The Cancer Letter archive.

Vol. 15 No. 03 | January 20, 1989

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI Contract Plans Shaping Up As RFP “Season” Approaches; L-B Profit Told

September 13, 1974

Clinton R&D Budget Amounts to a Cut, AAAS Study Says

April 18, 1997

Guest Editorial: The Academic Difference: George Weiner On How America’s Cancer Centers Are More Valuable Than Ever

October 31, 2014

In Brief: NCI To Work More Closely With Biotherapeutics, DeVita Says; apportionment May Be Abolished

February 12, 1988

In Brief: Newell Denies He’s Leaving For Job On West Coast, Says He Is A “Free Agent”

November 4, 1977

Sen. Grassley Presses Amgen on “Bundling.”

April 11, 2008